-

Komodo Health Appoints Edd Fleming to Board of Directors

Dr. Fleming brings decades of experience and leadership transforming operational performance across healthcare and life sciences

SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, a leader in software-driven health analytics, today announced the appointment of Edd Fleming, MD to its board of directors, further catalyzing the company’s role as the foundational enterprise technology and intelligence platform across the entire healthcare and life sciences ecosystem.

As a member of Komodo’s board, Dr. Fleming brings nearly 30 years of deep industry expertise developing growth strategies across pharma, biotech, medtech, and provider systems. In his role at McKinsey, he serves as the global leader of its R&D Practice, advising life sciences companies on ways to accelerate innovation and optimize product portfolios to address unmet medical needs across the healthcare ecosystem.

"We are pleased to welcome Edd to Komodo’s board of directors during a time of significant growth for our company,” said Arif Nathoo, MD, co-founder and CEO, Komodo Health. “His extensive experience as a veteran advisor across healthcare will be invaluable as we continue to scale Komodo’s work to close gaps in care and improve patient outcomes through data-driven insights.”

Dr. Fleming is trained in pulmonary, critical care, and internal medicine and holds a B.A. in Chemistry from Harvard University and an M.D. from Vanderbilt University. He also serves on the Board of Directors of CRISPR Therapeutics as well as the Board of Visitors for Vanderbilt’s School of Basic Sciences.

“Komodo Health’s mission to reduce the burden of disease through a deep, nuanced understanding of the real-world patient experience is essential to enable the patient centricity and precision that the industry strives to deliver,” said Dr. Fleming. “I look forward to working with Komodo’s board and leadership teams to help them bring this vision to full reality.”

With this appointment, Dr. Fleming joins Komodo Health’s seasoned management team, an experienced board of directors and accomplished founders with extensive experience across healthcare.

About Komodo Health
Komodo Health builds groundbreaking software solutions powered by our Healthcare Map™ — the industry’s largest and most comprehensive view of real-world, patient journey data. Komodo’s next-generation analytics make it easy to unlock meaningful insights and create more cost-effective, value-driven solutions that improve patient outcomes. In our mission to reduce the global burden of disease, we help healthcare and life sciences enterprises answer healthcare’s most complex questions. For more information, visit komodohealth.com.

Contacts

Christine Douglass
Komodo Health
media@komodohealth.com

Komodo Health


Release Versions

Contacts

Christine Douglass
Komodo Health
media@komodohealth.com

More News From Komodo Health

Komodo Health Appoints Mark Jewett to Chief Marketing Officer

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the leader in AI-powered healthcare intelligence, today announced the appointment of Mark Jewett as Chief Marketing Officer (CMO). Jewett will lead the company’s marketing, shaping brand, communications, and go-to-market strategy as it scales Marmot™ — its new AI platform designed to help Life Sciences and healthcare organizations innovate faster and serve patients better. The appointment comes following a period of significant momentum...

Komodo Health Analysis Uncovers Dual Reality in Metastatic Breast Cancer Care: Rapid Targeted Cancer Therapy Adoption Amid Glaring Age-Related Disparities

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--On the 40th anniversary of Breast Cancer Awareness Month, a new analysis from Komodo Health, the leader in AI-powered healthcare intelligence, conducted in collaboration with the Tigerlily Foundation, a national breast cancer patient advocacy organization, delivers critical insights into antibody-drug conjugate (ADC) treatment patterns in metastatic breast cancer. The study confirms growing clinical acceptance of this innovative therapy but also reveal...

Komodo Health Recognized by Forbes, TIME, and The Healthcare Technology Report for Healthcare Analytics AI Innovation

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the leader in AI-powered healthcare intelligence, today announced that it has earned recognition on three prestigious industry lists: the 2025 Forbes Cloud 100, TIME’s inaugural World’s Top HealthTech Companies, and The Healthcare Technology Report’s Top 25 Healthcare Software Companies. These honors validate Komodo’s differentiated approach to healthcare analytics AI — purpose-built from the ground up rather than retrofitted from consum...
Back to Newsroom